Cargando…

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models

OBJECTIVE: To investigate the clinical implications of 17β-estradiol (E2) in estrogen receptor α (ERα)-negative female cancer progression as well as the underlying biological mechanisms. METHODS: Clinical data from 306 locally-advanced cervical cancer (stage IIB-IVA) patients were analyzed in order...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozasa, Katsumi, Mabuchi, Seiji, Matsumoto, Yuri, Kuroda, Hiromasa, Yokoi, Eriko, Komura, Naoko, Kawano, Mahiru, Takahashi, Ryoko, Sasano, Tomoyuki, Shimura, Kotaro, Kodama, Michiko, Hashimoto, Kae, Sawada, Kenjiro, Nagasaka, Kazunori, Kimura, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443012/ https://www.ncbi.nlm.nih.gov/pubmed/30956772 http://dx.doi.org/10.18632/oncotarget.26711

Ejemplares similares

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
por: Kuroda, Hiromasa, et al.
Publicado: (2018)

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer
por: Shimura, Kotaro, et al.
Publicado: (2021)

Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies
por: Mabuchi, Seiji, et al.
Publicado: (2020)

Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review
por: Kozasa, Katsumi, et al.
Publicado: (2017)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016)

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
por: Kawano, Mahiru, et al.
Publicado: (2015)

Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer
por: Komura, Naoko, et al.
Publicado: (2019)

Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
por: Yokoi, Eriko, et al.
Publicado: (2017)

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
por: Shimura, Kotaro, et al.
Publicado: (2013)

Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
por: Matsuo, Koji, et al.
Publicado: (2015)

Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2018)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy
por: Mabuchi, Seiji, et al.
Publicado: (2022)

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types
por: Kobayashi, Masaki, et al.
Publicado: (2018)

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Safety and efficacy of Ninjin’yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
por: Yagi, Taro, et al.
Publicado: (2022)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Two cases of giant peritoneal inclusion cysts requiring treatment after total laparoscopic hysterectomy
por: Kozasa, Katsumi, et al.
Publicado: (2020)

Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study
por: Mabuchi, Seiji, et al.
Publicado: (2023)

Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2023)

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017)

Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy
por: Kuruma, Airi, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma
por: Kinose, Yasuto, et al.
Publicado: (2015)

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters
por: Isohashi, Fumiaki, et al.
Publicado: (2015)

Efferocytosis and autoimmune disease
por: Kawano, Mahiru, et al.
Publicado: (2018)

Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)
por: Oride, Tadashi, et al.
Publicado: (2023)

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
por: Nakamura, Koji, et al.
Publicado: (2019)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Comparison of the Injury Mechanism between Pregnant and Non-Pregnant Women Vehicle Passengers Using Car Crash Test Dummies
por: Kuwahara, Ayumu, et al.
Publicado: (2022)

Pacemaker implantation for sick sinus syndrome in a pregnant female with situs ambiguus and polysplenia
por: Hayashi, Tatsuya, et al.
Publicado: (2020)

To Be or Not to Be: Pregnant or Not
por: Patel, Bijal, et al.
Publicado: (2021)

QT Interval in Pregnant and Non-pregnant Women
por: Zamani, Majid, et al.
Publicado: (2014)

Changes, differences, and factors of parenthood in high-risk pregnant women and their partners in Japan
por: Kawamura, Eriko, et al.
Publicado: (2023)

Safe use of tocilizumab in pregnant women with Takayasu arteritis: three case studies
por: Konagai, Nao, et al.
Publicado: (2023)

Biomarkers of Radiosensitivity in A-Bomb Survivors Pregnant at the Time of Bombings in Hiroshima and Nagasaki
por: Miles, Edward F., et al.
Publicado: (2011)

A case of sarcomatoid malignant peritoneal mesothelioma diagnosed by laparoscopy
por: Kobayashi, Mariya, et al.
Publicado: (2020)

Artificial lactation by exogenous hormone treatment in non-pregnant sows
por: NOGUCHI, Michiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3hu84m7iosb9cnc5lrcm2lmm7b